Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Octopus Aim Share Price
  4. Octopus Aim Share Regulatory News
  5. Holding(s) in Company

Pin to quick picksOctopus Aim Regulatory News (OOA)

Octopus Aim Information

Share Price Information for Octopus Aim (OOA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 60.00
Ask: 63.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.00%)
Open: 61.50
High: 61.50
Low: 61.50
Prev. Close: 61.50
OOA Live PriceLast checked at -
Octopus AIM VCT is an Investment Trust

To invest in a broad range of AIM or NEX Exchange traded companies in order to provide shareholders with attractive tax-free dividends and long-term capital growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Aug 2008 18:27

RNS Number : 4874B
IS Pharma PLC
15 August 2008
 



IS Pharma plc

('IS Pharma' or the 'Company')

Notification of Interest

The Company was informed on 5 August 2008 that Close Investments Limited had a notifiable interest of 397,090 ordinary shares in IS Pharma, being 1.29% of the issued share capital of the Company. 

The change in notifiable interest follows the transfer of the three Close Brothers' AIM VCTs (Close Brothers AIM VCT, Close Second AIM VCT and Close IHT AIM VCT) to Octopus Investments Limited. Subsequent to this transfer Close Investments Limited no longer has a notifiable interest in ordinary 70 pence shares of IS Pharma. 

For further information, please call:

Financial Dynamics Limited  +44(0) 20 7831 3113

Billy Clegg / Edward Westropp

Noble & Company Limited  +44(0) 20 7763 2200

Matthew Hall / Sam Reynolds

IS Pharma +44(0) 1244 625150

Tim Wright, CEO

www.ispharma.plc.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLILFLDTVIELIT
12345678910
Date   Source Headline
10th Nov 202311:01 amGNWDirector/PDMR Shareholding
10th Nov 202311:00 amGNWIssue of Equity and Total Voting Rights
8th Nov 20231:20 pmGNWNet Asset Value(s)
7th Nov 20236:20 pmGNWHalf-Yearly Results
6th Nov 20236:00 pmGNWNet Asset Value(s)
1st Nov 202310:40 amGNWNet Asset Value(s)
1st Nov 20237:00 amGNWTotal Voting Rights and Capital
25th Oct 20238:50 amGNWNet Asset Value(s)
20th Oct 202311:30 amGNWOffers for Subscription – Over-Allotment Facility
19th Oct 20234:45 pmGNWPurchase of Own Securities and Total Voting Rights
18th Oct 202312:15 pmGNWNet Asset Value(s)
11th Oct 20233:50 pmGNWNet Asset Value(s)
10th Oct 202310:20 amGNWNet Asset Value(s)
6th Oct 20234:00 pmGNWNet Asset Value(s)
2nd Oct 20237:00 amGNWTotal Voting Rights and Capital
28th Sep 20237:00 amGNWNet Asset Value(s)
21st Sep 20234:45 pmGNWPurchase of Own Securities and Total Voting Rights
19th Sep 20233:30 pmGNWNet Asset Value(s)
15th Sep 20237:00 amGNWNet Asset Value(s)
14th Sep 202312:30 pmGNWPublication of Prospectus
13th Sep 20235:00 pmGNWPortfolio Update
8th Sep 20235:45 pmGNWNet Asset Value(s)
6th Sep 20235:00 pmGNWNet Asset Value(s)
1st Sep 20237:00 amGNWTotal Voting Rights and Capital
30th Aug 20239:20 amGNWNet Asset Value(s)
23rd Aug 20234:55 pmGNWNet Asset Value(s)
22nd Aug 20233:00 pmGNWPurchase of securities by Octopus Investments Nominees Limited
17th Aug 20235:15 pmGNWPurchase of Own Securities and Total Voting Rights
16th Aug 202312:55 pmGNWNet Asset Value(s)
10th Aug 20234:45 pmGNWIssue of Equity and Total Voting Rights
10th Aug 20234:40 pmGNWIssue of Equity and Total Voting Rights
9th Aug 202310:10 amGNWNet Asset Value(s)
8th Aug 20239:55 amGNWNet Asset Value(s)
1st Aug 20237:00 amGNWTotal Voting Rights and Capital
26th Jul 202310:10 amGNWNet Asset Value(s)
20th Jul 20235:00 pmGNWResults of Annual General Meeting
20th Jul 20234:30 pmGNWNet Asset Value(s)
13th Jul 20235:30 pmGNWPurchase of Own Securities and Total Voting Rights
12th Jul 202311:25 amGNWNet Asset Value(s)
12th Jul 20239:45 amGNWNet Asset Value(s)
7th Jul 20231:10 pmGNWNet Asset Value(s)
5th Jul 202310:00 amGNWIntention to Fundraise
3rd Jul 20237:00 amGNWTotal Voting Rights and Capital
28th Jun 202311:00 amGNWNet Asset Value(s)
21st Jun 20232:25 pmGNWNet Asset Value(s)
16th Jun 20236:30 pmGNWAnnual Report for the year ended 28 February 2023 and Notice of Meeting
16th Jun 20237:00 amGNWPurchase of Own Securities and Total Voting Rights
13th Jun 20234:20 pmGNWNet Asset Value(s)
9th Jun 202311:15 amGNWNet Asset Value(s)
8th Jun 202310:00 amGNWNet Asset Value(s)
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.